MedTrace Logo

Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses

NCT03942172 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-12-13

No results posted yet for this study

Summary

An open-label study to evaluate the effect of SpotOn balance glasses in non-demented Parkinson's patients with balance disorders.

Conditions

  • Parkinson Disease

Interventions

DEVICE

SpotOn balance glasses

SpotOn Balance Glasses comprising of personalized visual stimuli placed on the glasses's lenses

Sponsors & Collaborators

  • SpotOn Therapeutics Ltd.

    lead INDUSTRY

Principal Investigators

  • Ilana Shlezinger, MD · Rambam Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-27
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942172 on ClinicalTrials.gov